by Bruce Sylvester – Investigators from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage AcuteCoronary Syndromes (TRILOGY ACS) study reported at ESC 2012 no… read more.
In a press release on August 8, 2012, Amgen announced that the company was halting a late-stage trial of its monoclonal antibody IGF-1 receptor antagonist ganitumab (AMG-479).
In news that is bound to excite breast cancer patients and investors, Genentech/Roche/Immunogen issued press releases on August 26, 2012, confirming that their drug-of-the-moment T-DM1 (trastuzumab emtansine) offers… read more.
The end of July 2012 proved exciting for the world of biosimilar manufacturers. However, for the regulatory officials worldwide it meant more uncertainty and unknowns about proper, global… read more.
by Thomas R. Collins – Using everolimus for immunosuppression in heart transplant recipients, along with a reduced amount of cyclosporine, produces results comparable to mycophenolate mofetil,
by Thomas R. Collins – Candidates for a heart transplant who use a ventricular assist device on a long-term basis have survival rates on the wait list that… read more.
by Thomas R. Collins – TOL101, a new murine monoclonal antibody that targets the alpha-beta T-cell receptor, showed a good safety profile despite a problem with hives that… read more.
by Thomas R. Collins – Using a high dose of insulin is associated with a high risk of pancreas loss after a simultaneous pancreas kidney transplant, researchers said… read more.
by Thomas R. Collins – Total pancreatectomy and auto islet transplantation among children can bring about good results, with many able to stay insulin-free and almost all of… read more.
by Thomas R. Collins – The blood pressure of the kidney transplant recipient at the University of Glasgow kept climbing. But it wasn’t without effort from physicians.
by Thomas R. Collins – The functional status of transplant recipients is a factor that is often overlooked as kidneys are allocated,
by Thomas R. Collins – The BK virus, and damage to the kidney that is caused by it, poses a continuing challenge to kidney transplant specialists.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
